We are developing AAV-based strategies to enhance axonal regeneration after spinal cord injury, carefully timing interventions to minimize late-onset side effects. In parallel, we investigate the causes of post-injury pathophysiologies and test whether removing scar-related molecules can further drive regeneration - paving the way for future therapies.